Canine Demodicosis: Causes, Treatment, and Welfare

Demodicosis in Dogs: Understanding a Complex Skin Disease

Demodicosis — infestation with Demodex mites — ranges from a self-limiting minor skin condition in puppies to a severe, debilitating disease in immunocompromised adults. Understanding the pathophysiology, treatment options, and welfare implications of demodicosis guides appropriate veterinary management.

Demodex Mites: Normal Fauna Becoming Problematic

Demodex canis mites live in hair follicles as part of normal skin flora in all dogs. They are transmitted from dam to pup during nursing in the first days of life. Under normal immune conditions, mite populations remain small and controlled. When immune control is lost — through genetic predisposition in young dogs, or immune suppression in adults — mites proliferate causing disease.

Two additional Demodex species affect dogs: D. injai (tail, dorsum) and an unnamed short-bodied mite. These may require specific treatment adjustments.

Juvenile (Localised) Demodicosis

Localised demodicosis affects puppies aged 3-18 months, typically causing a few (under 5) circular patches of hair loss, scale, and mild erythema on the face or forelegs. This form reflects temporary immune immaturity and resolves spontaneously in approximately 90% of cases as immune competence develops. Treatment is often unnecessary; monitoring with occasional topical therapy is appropriate.

Generalised Demodicosis

Generalised demodicosis — involving the whole body or multiple large areas — represents serious disease with significant welfare implications:

Juvenile generalised: Affects puppies and young adults (under 18 months). Strongly heritable — affected animals should not be bred. Presents with widespread alopecia, scaling, comedones, follicular papules, and secondary bacterial pyoderma. Secondary deep pyoderma causes significant pain and systemic illness.

Adult-onset generalised: Develops in previously healthy adult dogs due to acquired immunosuppression — from neoplasia, hypothyroidism, hyperadrenocorticism, chemotherapy, or immunosuppressive medications. Underlying cause identification and management is critical to treatment success.

Welfare Impacts

Severe generalised demodicosis with secondary pyoderma causes: skin pain and pruritus, systemic infection (fever, lethargy, lymphadenopathy), psychological distress from chronic discomfort, and reduced quality of life. Identifying and managing the condition promptly minimises suffering duration.

Modern Treatment

Isoxazoline compounds (fluralaner, afoxolaner, sarolaner, lotilaner) have revolutionised demodicosis treatment, achieving 90-95%+ cure rates with convenient oral or spot-on dosing. Monthly or quarterly administration for 3-6 months typically achieves resolution. Resolution is confirmed by two negative deep skin scrapings 4 weeks apart. Traditional treatments (amitraz dips, oral ivermectin/milbemycin) remain alternatives but have lower convenience and safety profiles.

This page is part of the Animal Welfare Hub — providing evidence-based information to improve the lives of animals. Return to home.